ClinicalTrials.Veeva

Menu

Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease

F

Free University of Brussels (ULB)

Status

Completed

Conditions

Chronic Hepatitis C Virus
Alcoholic Liver Disease

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Alcoholic liver disease is characterized by circulating T cell activation and liver T cell infiltration but their phenotype is poorly studied. The aim of the study is to test the hypothesis that the (CD4+ T cell secreting Interleukin-17) Th17 pathway is involved in alcoholic liver disease.

Full description

Consecutive patients undergoing transjugular liver biopsies for alcoholic liver disease or hepatitis C virus infection will be included in the study to measure plasma cytokines levels, peripheral blood mononuclear cells cytokine release and liver T cell infiltrates.

Enrollment

49 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Alcohol excess intake and suspected liver disease
  • Alcohol excess intake and clinical liver cirrhosis
  • chronic hepatitis C virus infection and suspected liver disease
  • chronic hepatitis C virus infection and clinical liver cirrhosis

Exclusion criteria

  • bacterial or fungal infection
  • immunosuppressive treatment
  • other causes of liver disease

Trial design

49 participants in 2 patient groups

1
Description:
alcoholic liver disease
2
Description:
chronic hepatitis C virus infection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems